Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/9907
Title: | Imaginem oblivionis: the prospects of neuroimaging for early detection of Alzheimer's disease. | Austin Authors: | Villemagne, Victor L ;Rowe, Christopher C ;Macfarlane, S;Novakovic, K E;Masters, Colin L | Affiliation: | Department of Nuclear Medicine, Centre for PET, Austin Hospital, Melbourne, Victoria, Australia | Issue Date: | 1-Apr-2005 | Publication information: | Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia; 12(3): 221-30 | Abstract: | Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterised by the gradual onset of dementia. The pathological hallmarks of the disease are A beta amyloid plaques, neurofibrillary tangles, and reactive gliosis. Current diagnosis of AD is made by clinical, neuropsychologic, and neuroimaging assessments. Routine structural neuroimaging evaluation is based on non-specific features such as atrophy, a late feature in the progression of the disease, hence the crucial importance of developing new approaches for early and specific recognition at the prodromal stages of AD. Functional neuroimaging techniques such as positron emission tomography (PET) and single photon emission computed tomography (SPECT) could prove to be valuable in the differential diagnosis of AD, as well as in assessing prognosis. With the advent of new therapeutic strategies aimed at reducing the A beta amyloid burden in the brain, there is increasing interest in the development of PET and SPECT radioligands that will permit the assessment of A beta amyloid burden in vivo. From this, the prospect of specific preclinical diagnosis arises, possibly in conjunction with other related A beta biomarkers in plasma and CSF. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/9907 | DOI: | 10.1016/j.jocn.2004.03.011 | Journal: | Journal of Clinical Neuroscience | URL: | https://pubmed.ncbi.nlm.nih.gov/15851069 | Type: | Journal Article | Subjects: | Alzheimer Disease.diagnosis.genetics.metabolism.pathology.radionuclide imaging Amyloid beta-Peptides.metabolism Humans Neurofibrillary Tangles.metabolism.pathology Plaque, Amyloid.metabolism.pathology Positron-Emission Tomography Radiopharmaceuticals.diagnostic use Tomography, Emission-Computed, Single-Photon |
Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.